Presentation by Aaron Bailey, AbCellera: Leveraging the Versatility of Size Exclusion Coupled to Mass Spectrometry (SEC-MS) to Accelerate Antibody Drug Development
October 30 @ 8:00 am - 9:00 am
Presentation by Aaron Bailey, AbCellera: Leveraging the Versatility of Size Exclusion Coupled to Mass Spectrometry (SEC-MS) to Accelerate Antibody Drug Development